Skip to main content

Write a comment

Structured PREreview of A novel sustained release therapy of combined VEGF and TNF-α inhibitors leads to pan-ocular protection for months after severe ocular trauma

Published
DOI
10.5281/zenodo.10138538
License
CC BY 4.0
Does the introduction explain the objective of the research presented in the preprint?
Yes
Are the methods well-suited for this research?
Highly appropriate
Are the conclusions supported by the data?
Highly supported
Are the data presentations, including visualizations, well-suited to represent the data?
Highly appropriate and clear
How clearly do the authors discuss, explain, and interpret their findings and potential next steps for the research?
Very clearly
Is the preprint likely to advance academic knowledge?
Highly likely
Would it benefit from language editing?
No
Would you recommend this preprint to others?
Yes, it’s of high quality
Is it ready for attention from an editor, publisher or broader audience?
Yes, as it is

Competing interests

The author declares that they have no competing interests.

You can write a comment on this PREreview of A novel sustained release therapy of combined VEGF and TNF-α inhibitors leads to pan-ocular protection for months after severe ocular trauma.

Before you start

We will ask you to log in with your ORCID iD. If you don’t have an iD, you can create one.

What is an ORCID iD?

An ORCID iD is a unique identifier that distinguishes you from everyone with the same or similar name.

Start now